Ursula Theuretzbacher is an expert for antibacterial drug research, discovery/development strategies and policies based on clinical and public health needs. Her broad area of expertise includes public and philanthropic funding strategies for antibacterial drug R&D and initiatives to recover the global pipeline, evaluation and comparative assessment of antibacterial drugs, and optimization of antibacterial therapy concepts. She was member of the coordinating group of the WHO project Priority Pathogen List for R&D and leading scientist for the Clinical Pipeline analysis, and development of Target Product Profiles at WHO.